TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Cryogenetics AS
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
33,578
|
40,886
|
31,177 |
| Financial expenses |
1,651
|
1,074
|
940 |
| Earnings before taxes |
-5,910
|
8,580
|
3,668 |
| Total assets |
53,464
|
52,192
|
44,126 |
| Current assets |
14,452
|
26,268
|
23,389 |
| Current liabilities |
9,778
|
8,749
|
9,636 |
| Equity capital |
34,127
|
31,989
|
24,034 |
| - share capital |
4,428
|
4,428
|
4,428 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
63.8%
|
61.3%
|
54.5% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-17.6%
|
21.0%
|
11.8% |
| Return on assets (ROA) |
-8.0%
|
18.5%
|
10.4% |
| Current ratio |
147.8%
|
300.2%
|
242.7% |
| Return on equity (ROE) |
-17.3%
|
26.8%
|
15.3% |
| Change turnover | |||
| Change turnover % |
31%
|
9% | |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.